Minor histocompatibility antigens in human stem cell transplantation (Q35214671)

7 August 2017

1 reference

title

Minor histocompatibility antigens in human stem cell transplantation (English)

1 reference

7 August 2017

J H Frederik Falkenburg

1

1 reference

7 August 2017

Lisette van de Corput

2

1 reference

7 August 2017

Erik W A Marijt

3

1 reference

7 August 2017

Roel Willemze

4

1 reference

7 August 2017

1 September 2003

1 reference

7 August 2017

Experimental Hematology

1 reference

7 August 2017

31

1 reference

7 August 2017

9

1 reference

7 August 2017

743-751

1 reference

Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Ad

7 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

Bone marrow transplantation for acute myeloblastic leukaemia: an EBMT Leukaemia Working Party prospective analysis from HLA-typing

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

Minor H antigens: genes and peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoproteasome

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

The production of a new MAGE-3 peptide presented to cytolytic T lymphocytes by HLA-B40 requires the immunoproteasome

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

The importance of the proteasome and subsequent proteolytic steps in the generation of antigenic peptides.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

The human UTY gene encodes a novel HLA-B8-restricted H-Y antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

Identification of a graft versus host disease-associated human minor histocompatibility antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

The HA-2 minor histocompatibility antigen is derived from a diallelic gene encoding a novel human class I myosin protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

A human minor histocompatibility antigen resulting from differential expression due to a gene deletion

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

Tumor antigens recognized by T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

A human minor histocompatibility antigen specific for B cell acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

Identification of a novel HLA-B60-restricted T cell epitope of the minor histocompatibility antigen HA-1 locus

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

Identification of a polymorphic gene, BCL2A1, encoding two novel hematopoietic lineage-specific minor histocompatibility antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

Dendritic cells permit identification of genes encoding MHC class II-restricted epitopes of transplantation antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

Second class minors: molecular identification of the autosomal H46 histocompatibility locus as a peptide presented by major histocompatibility complex class II molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

Polymorphism of adhesion molecule CD31 and its role in acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

Y-antigen killing by T cells of women is restricted by HLA

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

Rejection of bone-marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

Acute graft-versus-host disease does not require alloantigen expression on host epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

Understanding the alloresponse: new approaches to graft-versus-host disease prevention.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

Identical-twin bone marrow transplants for leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

Growth inhibition of clonogenic leukemic precursor cells by minor histocompatibility antigen-specific cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

CD8(+) minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

The hematopoietic system-specific minor histocompatibility antigen HA-1 shows aberrant expression in epithelial cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

Expression and induction of costimulatory and adhesion molecules on acute myeloid leukemic cells: implications for adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

Expression of human leucocyte antigens and co-stimulatory molecules on blasts of patients with acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

Anti-inflammatory cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

Tumor-derived TGF-beta reduces the efficacy of dendritic cell/tumor fusion vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

Dendritic cells in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900190-5

7 January 2021

10.1016/S0301-472X(03)00190-5

Identifiers

DOI

1 reference

7 August 2017

1 reference